tryptophan has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Candolfi, M; Chiappini, FA; Miret, NV; Monczor, F; Nicola Candia, AJ; Pontillo, CA; Randi, AS; Zappia, CD; Zárate, LV | 1 |
| Bernard, JJ; Diedrich, JD; Ensink, E; Gonzalez-Pons, R; Liby, KT; Lunt, SY; Medeiros, HCD; Wellberg, EA | 1 |
| Sordillo, LA; Sordillo, PP | 1 |
| Calvo, D; Cordón, L; Font de Mora, J; García, A; Hervás, D; Panadero, J; Quintas, G; Ripoll, F; Salvador-Coloma, C; Sanmartín, E; Santaballa, A | 1 |
| Bilir, C; Guney Eskiler, G | 1 |
| Christenson, JL; Cittelly, DM; D'Alessandro, A; Degala, GD; Gordon, MA; Greene, LI; Lambert, JR; Nemkov, T; O'Neill, KI; Richer, JK; Rogers, TJ; Shin, J; Tan, AC; Williams, MM | 1 |
| Burns, KE; Robinson, MK; Thévenin, D | 1 |
1 review(s) available for tryptophan and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Suppression of Kynurenine 3-Monooxygenase as a Treatment for Triple-negative Breast Carcinoma.
Topics: Brain; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Kynurenine 3-Monooxygenase; Treatment Outcome; Triple Negative Breast Neoplasms; Tryptophan | 2023 |
6 other study(ies) available for tryptophan and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Breast cancer progression and kynurenine pathway enzymes are induced by hexachlorobenzene exposure in a Her2-positive model.
Topics: Cell Line, Tumor; Dioxygenases; Estrogen Receptor beta; Female; Hexachlorobenzene; Humans; Kynurenine; Pesticides; Receptors, Aryl Hydrocarbon; Triple Negative Breast Neoplasms; Tryptophan; Vascular Endothelial Growth Factor A | 2023 |
Adipocyte-derived kynurenine stimulates malignant transformation of mammary epithelial cells through the aryl hydrocarbon receptor.
Topics: Adipocytes; Epithelial Cells; Hormones; Humans; Kynurenine; Ligands; Receptors, Aryl Hydrocarbon; Triple Negative Breast Neoplasms; Tryptophan | 2023 |
Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Cells, Cultured; Coculture Techniques; Exosomes; Female; Humans; Immune Tolerance; Immunohistochemistry; Indoleamine-Pyrrole 2,3,-Dioxygenase; Liquid Biopsy; Metabolomics; MicroRNAs; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Triple Negative Breast Neoplasms; Tryptophan | 2020 |
The efficacy of indoximod upon stimulation with pro-inflammatory cytokines in triple-negative breast cancer cells.
Topics: B7-H1 Antigen; Cell Line, Tumor; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Humans; Inflammation Mediators; Interferon-gamma; Treatment Outcome; Triple Negative Breast Neoplasms; Tryptophan; Tumor Necrosis Factor-alpha | 2021 |
Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression.
Topics: Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Kynurenine; MicroRNAs; Triple Negative Breast Neoplasms; Tryptophan; Tryptophan Oxygenase | 2019 |
Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.
Topics: Aminobenzoates; Animals; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Chemistry, Pharmaceutical; Circular Dichroism; Drug Delivery Systems; Female; HeLa Cells; Humans; Hydrogen-Ion Concentration; Membrane Proteins; Mice; Neoplasm Transplantation; Oligopeptides; Peptides; Phosphatidylcholines; Spectrometry, Fluorescence; Triple Negative Breast Neoplasms; Tryptophan | 2015 |